Literature DB >> 14259942

THERAPY OF TOXOPLASMOSIS UVEITIS.

M GHOSH, P M LEVY, I H LEOPOLD.   

Abstract

Keywords:  ACETAZOLAMIDE; ASCORBIC ACID, THERAPEUTIC; CHORIORETINITIS; DRUG THERAPY; METHYLPREDNISOLONE; MYDRIATICS; PHENYLEPHRINE; PREDNISOLONE, TOPICAL; PYRIMETHAMINE; SULFAMETHOXYPYRIDAZINE; TOXICOLOGIC REPORT; TOXOPLASMOSIS, OCULAR; UVEITIS

Mesh:

Substances:

Year:  1965        PMID: 14259942     DOI: 10.1016/0002-9394(65)95020-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  4 in total

1.  Treatment of active toxoplasmic retino-choroiditis.

Authors:  J Nolan; E S Rosen
Journal:  Br J Ophthalmol       Date:  1968-05       Impact factor: 4.638

Review 2.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 3.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

4.  Azithromycin versus Sulfadiazine and Pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: a pilot study.

Authors:  Konstantinos Balaskas; Jean Vaudaux; Noémie Boillat-Blanco; Yan Guex-Crosier
Journal:  Med Sci Monit       Date:  2012-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.